Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-13

FDA Approved: TIMOLOL MALEATE — Original Application (Ingenus Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved Ingenus Pharmaceuticals' original ANDA for Timolol Maleate ophthalmic solution, sanctioning a generic treatment option for open-angle glaucoma and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Timolol maleate (Timolol maleate)

Snippet

ORIG AP for TIMOLOL MALEATE (TIMOLOL MALEATE)